That's what we want to do, but Shropdoc, remember, has financial problems of its own and that's the reason why this situation has arisen. One of the concerns as well is that the two English clinical commissioning groups that currently commission Shropdoc will re-tender during 2018 and, of course, it's important that both sides of the border work together in order to commission a new service. But this is not a situation where the health board have chosen to be in a position where they want to offload Shropdoc, if I can put it that way. It's because of Shropdoc's financial challenges that the situation has arisen. But everybody wants to get to a situation where the service is at least as good as the service that currently exists.